Company intelligence / Profile preview

Wuxi WE Medical Technology

Shanghai, Shanghai, Chinamd.wuxiapptec.com ↗

Ownership: Private
Employees: ~38000
Development stage: Commercial

Overview

WuXi AppTec is a leading global CRO/CDMO providing integrated R&D and manufacturing services across small molecules, biologics, oligonucleotides, peptides, and medical devices. It enables pharmaceutical companies worldwide to accelerate drug discovery and development. The company has extensive regulatory accreditations globally. Its US-based medical device testing business was acquired by NAMSA in early 2025.

Modalities: Small moleculeBiologicOligonucleotidePeptide
Industry: Drug Discovery Services

Partnerships

Joint ventures with AstraZeneca’s MedImmune armPRA Health Sciences/PRA InternationalCollaborates with thousands of pharma/biotech clients globally

Beyond the preview

Go deeper on Wuxi WE Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuxi WE Medical Technology.

Explore the full profile